Sentien Biotechnologies Names Richard Ganz as Executive Chairman
Filter: PRESS RELEASES IN THE NEWS EVENTS
Sentien Biotechnologies Names Richard Ganz as Executive Chairman
LEXINGTON, MA – Sentien Biotechnologies, Inc., a clinical-stage biotechnology company developing novel approaches to cell therapy, today announced the appointment of Richard Ganz as Executive Chairman. Mr. Ganz will continue to lead Sentien’s Board of Directors, a role he has filled for the past nine years, as well as work closely with CEO Brian Miller and Sentien’s management team.
